Detalhe da pesquisa
1.
Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis.
Mol Carcinog
; 58(11): 1960-1973, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31355511
2.
New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer.
Br J Cancer
; 114(4): 469-76, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26812573
3.
EGFR mutation testing practice in advanced non-small cell lung cancer.
Lung
; 192(5): 759-63, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24964874
4.
Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit.
Sci Rep
; 13(1): 2007, 2023 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737654
5.
Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer.
Lung Cancer
; 178: 229-236, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898331
6.
Effects of EGFR driver mutations on pathologic regression in resectable locally advanced non-small cell lung cancer treated with neoadjuvant chemoradiation and completion surgery.
Br J Radiol
; 96(1152): 20220763, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37751214
7.
UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN).
J Thorac Oncol
; 18(2): 169-180, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307041
8.
RCC Real-World Data: Prognostic Factors and Risk Stratification in the Immunotherapy Era.
Cancers (Basel)
; 14(13)2022 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35804899
9.
Immune-Related Thyroiditis as a Predictor for Survival in Metastatic Renal Cell Carcinoma.
Cancers (Basel)
; 14(4)2022 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35205622
10.
Liquid First Is "Solid" in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation Sequencing.
Front Oncol
; 12: 912801, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35785173
11.
Chemoradiation followed by adjuvant durvalumab in stage III non-small cell lung cancer: Real-world comparison of treatment outcomes to historical controls treated with chemoradiation alone.
Thorac Cancer
; 13(12): 1763-1771, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538909
12.
Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program.
Ther Adv Med Oncol
; 14: 17588359221103206, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35720834
13.
Real World Outcomes and Hepatotoxicity of Infliximab in the Treatment of Steroid-Refractory Immune-Related Adverse Events.
Curr Oncol
; 28(3): 2173-2179, 2021 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34208089
14.
Genomic Landscape of Malignant Peripheral Nerve Sheath TumorâLike Melanoma.
J Invest Dermatol
; 141(10): 2470-2479, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33831431
15.
Cancer Patient-Reported Preferences and Knowledge for Liquid Biopsies and Blood Biomarkers at a Comprehensive Cancer Center.
Cancer Manag Res
; 12: 1163-1173, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32104096
16.
RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients.
Clin Lung Cancer
; 18(4): e223-e232, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28082048
17.
Characteristics of Immune Checkpoint Inhibitors Trials Associated With Inclusion of Patients With HIV: A Systematic Review and Meta-analysis.
JAMA Netw Open
; 2(11): e1914816, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31702796
18.
Serum thymidine kinase 1 activity in the prognosis and monitoring of chemotherapy in lung cancer patients: a brief report.
J Thorac Oncol
; 9(10): 1568-72, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25521401